Welcome to our dedicated page for Nutex Health news (Ticker: NUTX), a resource for investors and traders seeking the latest updates and insights on Nutex Health stock.
Nutex Health Inc. (NASDAQ: NUTX) is a Houston, Texas-based, physician-led healthcare management and operations company with a growing network of micro-hospitals, specialty hospitals and hospital outpatient departments, along with primary care-centric, risk-bearing physician networks. The Nutex Health news feed highlights how this integrated healthcare delivery system evolves through facility openings, reopenings, financial results and corporate actions.
Investors and observers can use the Nutex Health news page to follow announcements about new and reopened hospitals such as Bayou City ER & Hospital near Houston, Red River ER & Hospital in Sherman, Texas, and Archview ER & Hospital in St. Louis, Missouri. These updates often describe facility capabilities, including emergency and inpatient beds, full-service laboratories and advanced imaging technology, as well as the company’s stated focus on concierge-level care and access to services around the clock.
Regular news releases also cover Nutex Health’s quarterly and annual financial results, segment performance for its hospital and population health management divisions, and non-GAAP measures such as EBITDA and Adjusted EBITDA. The company uses these reports to discuss revenue trends, hospital visit volumes, arbitration-related revenue through the Independent Dispute Resolution (IDR) process and cash flow from operating activities. Other items appearing in Nutex Health news include restatements of prior financial statements, Nasdaq listing compliance updates, stock repurchase program authorizations and information about legal or regulatory matters such as short seller reports and derivative litigation.
By reviewing the Nutex Health (NUTX) news page, readers can track how the company’s facility footprint, financial profile and governance disclosures change over time. The page aggregates press releases and related updates in one place, making it easier to monitor developments that the company has chosen to highlight in its public communications.
NUTEX HEALTH (NASDAQ: NUTX) appointed Wesley Bamburg as Chief Operating Officer, effective October 13, 2025. Bamburg brings 20 years of Fortune 500 healthcare experience and prior COO roles at HCA Houston Healthcare Medical Center (2019–2024) and HCA Houston Healthcare North Cypress (since July 2024).
The company said Bamburg's background in operations, payor contracting, integrated network management, and physician relations will support Nutex Health's physician-led micro hospital and outpatient expansion across 11 states.
Nutex Health (NASDAQ: NUTX) reported preliminary Q3 2025 operational metrics showing patient volume up 11.1% year‑over‑year (46,293 visits vs. 41,668) and a cash collections increase of 258.8% in Q3 2025 ($235,003k vs. $65,501k). Year‑to‑date patient visits rose 14.0% and YTD cash collections increased 176.9%. Management labels these figures as preliminary estimates subject to final accounting adjustments.
The company disclosed an ongoing restatement related to accounting for earn‑out obligations from a 2022 merger, leading to previously issued statements being unreliable, a Nasdaq non‑compliance notice, and a Nasdaq‑granted exception to file the delinquent Form 10‑Q for June 30, 2025 by December 12, 2025. The Q3 2025 Form 10‑Q will be filed after completing the restatement and related filings.
Nutex Health (NASDAQ: NUTX) announced it earned a record‑breaking 20 awards and honors in the third quarter of 2025, the most in company history, the PR states.
The awards span its network of 24 micro hospitals and HOPDs across 11 states and include community‑voted recognitions for emergency care, hospitals, pediatric services, workplace, CIHQ accreditation at multiple facilities, and a corporate Horizon Award for patient financial experience.
Nutex Health (NASDAQ: NUTX), a physician-led healthcare system operating 24 micro hospitals across 11 states, has appointed Wesley Bamburg as its new Chief Operating Officer, effective October 13, 2025. Bamburg brings 20 years of Fortune 500 healthcare experience, most recently serving as COO at HCA Houston Healthcare North Cypress.
Bamburg's extensive background includes leadership roles in healthcare operations, payor contracting, and physician relations. He holds a BS in Healthcare Administration and an MBA, and is a Fellow of the American College of Healthcare Executives. The appointment strengthens Nutex Health's leadership team as it continues expanding its innovative, patient-centric healthcare delivery model.
[ "Appointment of seasoned healthcare executive with 20 years of Fortune 500 experience", "New COO brings extensive experience in payor contracting and physician relations", "Strong educational background and professional credentials (FACHE certification)", "Previous leadership experience at major healthcare organization (HCA Healthcare)" ]Nutex Health (NASDAQ: NUTX), a healthcare system with 24 micro hospitals across 11 states, announced significant financial restatements and preliminary Q2 2025 results. The company must restate its Q1 2025 and FY 2024/2023 financial statements due to non-cash classification changes related to hospital construction obligations.
Despite these accounting adjustments, Nutex reported strong Q2 2025 performance with revenue increasing 220.7% to $244.0 million and record quarterly cash collections of $175 million. The company achieved an Adjusted EBITDA of $71.6 million, up from $6.8 million in Q2 2024.
However, Nutex received a Nasdaq delinquency notice for delayed Q2 2025 filing and must submit a compliance plan by October 20, 2025, to avoid potential delisting risks.
Nutex Health (NASDAQ: NUTX), a physician-led healthcare system with 24 micro hospitals across 11 states, announced three significant updates: preliminary Q2 2025 results, a Form 10-Q filing delay, and a $25 million stock repurchase program.
The company reported strong Q2 2025 performance with revenue of $244.0 million, up 220.7% year-over-year, and gross profit of $124.9 million (51.2% margin). Total hospital visits increased by 10.6% to 45,573. For H1 2025, revenue reached $455.8 million, up 217.5%, with gross profit of $243.3 million.
The Form 10-Q filing delay is due to non-cash accounting adjustments related to stock-based compensation for under-construction hospitals. The company expects to file within the five-day grace period and confirms these adjustments won't affect revenue, gross profit, or operations.
Nutex Health (NASDAQ: NUTX), a physician-led healthcare system operating 24 micro hospitals across 11 states, has scheduled its Q2 2025 financial results announcement. The company will release its second quarter results on Thursday, August 14, 2025 after market close, followed by a conference call on Friday, August 15, 2025 at 10:30 a.m. ET.
Investors can access the conference call via phone at 1-877-407-9208 or 1-201-493-6784, or through the participant link. A recording will be available on the company's website for those unable to attend the live call.
Nutex Health (NASDAQ: NUTX), a physician-led healthcare delivery system, has announced plans to ring the Nasdaq closing bell in New York City on August 26, 2025. The company will also host an investor meet and greet session in Midtown Manhattan from 9 AM to 1 PM EST on the same day.
Nutex Health operates 24 facilities across 11 states, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). The company's structure consists of two main divisions: a Hospital Division and a Population Health Management Division, which manages provider networks such as Independent Physician Associations (IPAs).
Nutex Health (NASDAQ: NUTX), a physician-led healthcare system operating 24 micro hospitals and HOPDs across 11 states, has issued a formal response to a recent short seller report. The company strongly refutes allegations regarding its collection process, stating that the report contains misrepresentations and demonstrates a misunderstanding of their business model.
Nutex Health emphasizes its robust internal process for coding, billing, and handling medical claims through independent dispute resolution when necessary. The company plans to provide additional updates in its upcoming Q2 2025 earnings release and Form 10-Q, expected by August 14, 2025.
Nutex Health (NASDAQ: NUTX), a physician-led healthcare system operating 24 micro hospitals and HOPDs across 11 states, has announced multiple community awards received during Q2 2025. The company's facilities earned recognition in various categories, including Best Emergency Care and Top Doc Awards.
Notable achievements include awards for The Colony ER Hospital, Wylie ER, Milwaukee ER & Hospital, Tucson ER & Hospital, and Texarkana Emergency Center & Hospital. Additionally, CEO Dr. Tom Vo was named a "Most Admired CEO Honoree" by the Houston Business Journal. These community-voted accolades reflect the company's commitment to patient-centric healthcare delivery.
FAQ
What is the current stock price of Nutex Health (NUTX)?
What is the market cap of Nutex Health (NUTX)?
